Jae Joon Park

Soonchunhyang University Hospital Seoul

Papers

1

Total Citations

14

H-Index

1

About

Dr. Jae Joon Park is a urologic oncologist whose research focuses on optimizing surgical decision-making for renal tumors, particularly through evidence-based assessments of pathology and outcomes. His most impactful work, a systematic review and meta-analysis published in 2020, rigorously examined the prevalence of benign pathology after partial nephrectomy for suspected renal tumors. This study, which has garnered 14 citations, synthesized data from multiple databases to reveal that a significant proportion of surgically removed renal masses are benign, challenging assumptions about malignancy and highlighting the need for improved preoperative risk stratification. By identifying predictive factors for benign pathology, Dr. Park’s research directly informs clinical practice, helping to reduce unnecessary surgeries and their associated risks. His contributions underscore a commitment to refining nephron-sparing approaches and advancing personalized care in urologic oncology. Through this work, Dr. Park has established himself as a key voice in the ongoing effort to balance oncologic efficacy with quality of life for patients facing renal surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Prevalence of benign pathology after partial nephrectomy for suspected renal tumor: A systematic review and meta-analysis
14 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Soonchunhyang University Hospital Seoul

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago